Sharekhan

#SharekhanFNA #SharekhanResearch retains Buy rating on #DrReddys (PT Rs5550) concerns to slow down US sales growth… https://t.co/VGbz2DidY6 #SharekhanFNA #SharekhanResearch #DrReddys

#SharekhanResearch retain +ve view on Macrotech Devs with upside potential of 31-33%, Sales & Collections up 35%+ y… https://t.co/11KGAXXooE #SharekhanResearch

#SharekhanResearch retains Buy on #TCS with a PT of Rs. 4,600; healthy numbers for Q4FY22, with slight beat in reve… https://t.co/InYLhoyUsC #SharekhanResearch #TCS

#SharekhanResearch retains Buy on Welspun India with PT of Rs130; Supply constraints & RM inflation will affect nea… https://t.co/IUJ6iJWRg9 #SharekhanResearch

#SharekhanResearch Q4FY22 Cons. Disc. preview: Double digit rev. growth for retail cos; it will be lower vs. Q3 imp… https://t.co/vUO84x4Y71 #SharekhanResearch

#SharekhanResearch oil & gas Q4 preview – Oil price rally to boost PAT of ONGC/Oil India but dent earnings of OMCs… https://t.co/lAm7SyPIWj #SharekhanResearch

#SharekhanResearch initiated viewpoint on Symphony with Positive view and (20-22% upside), market leader to benefit… https://t.co/Z9k2hXiprM #SharekhanResearch

#SharekhanResearch re-iterates Buy on HUL with PT of Rs2456; The stock has corrected by 23% in last 6mths underperf… https://t.co/29fVg2OEqo #SharekhanResearch

#SharekhanResearch retains Buy on Mastek with PT of Rs. 3,840; we expect its revenue growth to pick-up in Q4FY22, a… https://t.co/IPYZhDzAz2 #SharekhanResearch